Nirvana Life Sciences Inc. (CSE:NIRV)
Canada
· Delayed Price · Currency is CAD 0.0700
-0.0300 (-30.00%)
At close: Nov 17, 2025
-90.67% (1Y)
| Market Cap | 1.60M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -346.30K |
| Shares Out | 22.82M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Average Volume | 4,089 |
| Open | 0.0700 |
| Previous Close | 0.1000 |
| Day's Range | 0.0700 - 0.0700 |
| 52-Week Range | 0.0300 - 0.5000 |
| Beta | -0.07 |
| RSI | 45.17 |
| Earnings Date | Dec 9, 2025 |